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Strategies for Reducing Exposure to
Environmental Tobacco Smoke,
Increasing Tobacco-Use Cessation, and
Reducing Initiation in Communities and
Health-Care Systems
A Report on Recommendations of the
Task Force on Community Preventive Services
Summary
Reducing tobacco-related morbidity and death is an ongoing challenge for
health-care providers, health-care systems, and public health programs.
Interventions are available that a) reduce exposure to environmental tobacco
smoke, b) reduce tobacco-use initiation,* and c) increase tobacco-use cessation.†
The Task Force on Community Preventive Services has conducted systematic
reviews on 14 selected interventions, which are appropriate for communities and
health-care systems, and has made recommendations regarding use of these
interventions. This report summarizes the recommendations, identifies sources
that offer full reviews of the interventions and details about applying the
interventions locally, and provides an update of the Task Force’s work.
BACKGROUND
In the United States, tobacco use is the leading cause of preventable death (1–3 ), and
exposure to environmental tobacco smoke (ETS) is a preventable cause of significant
morbidity and death among nonsmokers (4–6 ). Reducing tobacco use and reducing
exposure to environmental tobacco smoke are essential community and public health
objectives (7 ). As part of the Healthy People 2010  initiative (7 ), goals have been devel-
oped to reduce tobacco-related morbidity and death by reducing exposure to ETS,
decreasing tobacco-use initiation, and increasing tobacco-use cessation (Table 1).
By implementing interventions shown to be effective, policy makers and health-care
and public health providers can help their communities achieve these goals while using
community resources efficiently. This report and other related publications provide guid-
ance from the Task Force on Community Preventive Services to personnel in state and
local health departments, managed care organizations, purchasers of health care, per-
sons responsible for funding public health programs, and others who have interest in or
responsibility for decreasing tobacco use and reducing exposure to environmental
tobacco smoke in all segments of the population.
*Tobacco-use initiation is defined as the onset, development, and establishment of tobacco-
use behavior.
† Tobacco-use cessation is defined as a process that begins with the decision to stop using
tobacco and ends with long-term maintenance of abstinence from tobacco.
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TABLE 1. Selected objectives for reducing tobacco use and exposure to environmental
tobacco smoke — Healthy People 2010
Targeted condition Population Percentage of population
Baseline* 2010 objective
Cigarette smoking Adults 24% (1997) Decrease to 12%.
Tobacco use Adolescents
 (past month) (grades 9–12) 43% (1997) Decrease to 21%.
Smoking cessation Pregnant women 12% (1991) Increase to 30%.
Smoking cessation Adult smokers 43% (1997) Increase to 75%.
attempts
Smoking cessation Adolescent smokers 73% (1997) Increase to 84%.
attempts
Exposure to environmental Nonsmokers 65% (1994) Decrease to 45%.
tobacco smoke
Exposure to environmental Children 27% (1994) Decrease to 10%.
tobacco smoke at home
* Years indicate when the data were analyzed to establish baseline estimates. Some estimates
are age-adjusted to the year 2000 standard population.
Source: US Department of Health and Human Services. Healthy people 2010 (conference ed,
in 2 vols). Washington, DC: US Department of Health and Human Services, 2000.
INTRODUCTION
The independent, nonfederal Task Force on Community Preventive Services (the
Task Force) is developing the Guide to Community Preventive Services  (the Commu-
nity Guide ) with the support of the U.S. Department of Health and Human Services and
in collaboration with public and private partners. CDC and other federal agencies pro-
vide staff support to the Task Force for development of the Community Guide. How-
ever, the recommendations presented in this report were developed by the Task Force
and are not necessarily the recommendations of CDC or the U.S. Department of Health
and Human Services.
This MMWR report is the second to be completed for the Community Guide, a
resource that will include multiple chapters, each focusing on a preventive health topic.
The first chapter was on vaccine-preventable diseases (8–11 ), and the information in
this report will be part of a second chapter, on tobacco use. This report provides an
overview of the process used by the Task Force to select and review evidence; it sum-
marizes the Task Force’s recommendations on community interventions to reduce
exposure to ETS and tobacco use. A full presentation of the recommendations, support-
ing evidence, and remaining research questions will be published in the American Jour-
nal of Preventive Medicine  in 2001.
For more information about this report, please call the Office on Smoking and Health
(OSH) press line at 770-488-5493. Copies of this report may be obtained through OSH’s
Web site at <http://www.cdc.gov/tobacco> or by calling 770-488-5705 (press 3 to talk to
an information specialist).
METHODS
Methods used to conduct systematic reviews and link evidence to recommendations
have been described elsewhere (12 ). In brief, for each Community Guide  chapter,
multidisciplinary chapter development teams conduct reviews by
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• developing an approach to organizing, grouping, and selecting the interventions for
review;
• systematically searching for and retrieving evidence;
• assessing the quality of the body of evidence of effectiveness for interventions and
summarizing the strength of this body of evidence;
• summarizing information regarding other evidence (e.g., applicability of the
intervention to different populations and settings, additional benefits, potential
harms, barriers to implementation, and economic evaluations); and
• identifying and summarizing research gaps.
For the chapter on tobacco use, the chapter development team focused on interven-
tions to decrease exposure to ETS, reduce tobacco-use initiation, and increase tobacco-
use cessation. The chapter consultation team members* generated a comprehensive
list of strategies and created a priority list of interventions for review based on their
perception of the importance and the extent to which the interventions were practiced in
the United States. Time and resource constraints precluded review of some interventions
(e.g., communitywide risk factor screening and counseling).
Interventions reviewed were either single-component (i.e., using only one activity to
achieve desired outcomes) or multicomponent (i.e., using more than one related activ-
ity). Interventions were grouped together on the basis of their similarity. Some studies
provided evidence for more than one intervention. In these cases, the studies were
reviewed for each applicable intervention. The classifications or nomenclature used in
this report were chosen to ensure comparability in the review process, and these classi-
fications sometimes differ from those used in the original studies.
To be included in the reviews of effectiveness, studies had to meet these criteria:
a) they were limited to primary investigations of interventions selected for evaluation;
b) they were published in English from January 1980 through May 2000; c) they were
conducted in industrialized countries; and d) they compared outcomes in groups of per-
sons exposed to the intervention with outcomes in groups of persons not exposed or less
exposed to the intervention (whether the comparison was concurrent or before-after).
For each intervention reviewed, the team developed an analytic framework indicat-
ing possible causal links between the intervention under study and predefined out-
comes of interest. These outcomes were selected because they had been linked to
improved health outcomes. For example, the Task Force concluded the following:
*Consultants for the chapter on preventing tobacco use and exposure were Dileep G. Bal,
M.D., California Department of Health Services, Sacramento, California; Anthony Biglan,
Ph.D., Oregon Research Institute, Eugene, Oregon; Patricia A. Buffler, Ph.D., M.P.H., University
of California, Berkeley, California; Gregory Connolly, D.M.D., M.P.H., Massachusetts Tobacco
Control Program, Boston, Massachusetts; K. Michael Cummings, Ph.D., M.P.H., Roswell Park
Institute, Buffalo, New York; Michael C. Fiore, M.D., M.P.H., University of Wisconsin Medical
School, Madison, Wisconsin; David W. Fleming, M.D., CDC, Atlanta, Georgia; Sally Malek,
M.P.H., North Carolina Department of Health, Raleigh, North Carolina; Patricia A, Mullen,
Dr.P.H., University of Texas Health Sciences Center, Houston, Texas; Cheryl L. Perry, Ph.D.,
University of Minnesota, Minneapolis, Minnesota; John P. Pierce, Ph.D., University of
California, San Diego, California; Helen H. Schauffler, Ph.D., University of California, Berkeley,
California; Randy H. Schwartz, M.S.P.H., Maine Bureau of Health, Augusta, Maine; and Mitchell
Zeller, American Legacy Foundation, Washington, DC.
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• Tobacco use is a cause of morbidity (illness and disability) and death (2,3,13 ).
• Tobacco-use cessation reduces tobacco-related morbidity and death (2,14 ).
• Delivery of advice by health-care providers to tobacco-using patients to quit has a
small but significant impact on tobacco-use cessation among patients (15,16 ).
• The younger persons are when they begin to smoke, the more likely they are to be
current smokers as adults — an indication that postponing or preventing tobacco
use among children and adolescents will decrease the number of adult tobacco
users (17 ).
• Exposure to ETS is a cause of morbidity and death (4–6 ), and reducing exposure
to ETS can be assumed to reduce ETS-associated morbidity and death.
The evaluations of interventions in this report, therefore, focus on evidence of effec-
tiveness in reducing ETS exposure, reducing tobacco-use initiation, and increasing
tobacco-use cessation (including increasing patient receipt of advice to quit from health-
care providers).
Each study that met the inclusion criteria was evaluated by using a standardized
abstraction form and was assessed for suitability of the study design and threats to
validity. On the basis of the number of threats to validity, studies were characterized as
having good, fair, or limited execution (12 ). The strength of the body of evidence of
effectiveness was characterized as strong, sufficient, or insufficient on the basis of the
number of available studies, the suitability of study designs for evaluating effective-
ness, the quality of execution of the studies, the consistency of the results, and the
effect size (12 ).
The Community Guide  links evidence to recommendations systematically (12 ). The
strength of evidence of effectiveness corresponds directly to the strength of recom-
mendations (e.g., strong evidence of effectiveness corresponds to an intervention be-
ing strongly recommended, and sufficient evidence corresponds to an intervention
being recommended). Other types of evidence also can affect a recommendation. For
example, evidence of harms resulting from an intervention might lead to a recommen-
dation that the intervention not be used, even if it is effective in improving some out-
comes. In general, the Task Force does not use economic information to modify
recommendations.
A finding of insufficient evidence of effectiveness does not result in recommenda-
tions regarding an intervention’s use but is important for identifying areas of uncer-
tainty and continuing research needs. In contrast, adequate evidence of ineffectiveness
leads to a recommendation that the intervention not be used.
RESULTS
The systematic search identified 243 studies on tobacco interventions that met the
inclusion criteria. Of these 243 studies, 77 were excluded on the basis of limitations in
their execution or design and were not considered further. The remaining 166 studies
were considered qualifying studies.* The 14 Task Force evaluations in this report are
based on these qualifying studies, all of which had good or fair execution.
*Additional information on the qualifying studies will be available at <http://
www.thecommunityguide.org>.
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On the basis of the evidence of effectiveness, the Task Force either strongly recom-
mended or recommended nine of the 14 strategies evaluated (Table 2). These nine
recommendations include one intervention to reduce exposure to ETS (smoking bans
and restrictions), two interventions to reduce tobacco-use initiation (increasing the unit
price for tobacco products and multicomponent mass media campaigns), and six inter-
ventions to increase cessation (increasing the unit price for tobacco products; multi-
component mass media campaigns; provider reminder systems; a combined provider
reminder plus  provider education with or without  patient education program; multicom-
ponent interventions including telephone support for persons who want to stop using
tobacco; and reducing patient out-of-pocket costs for effective cessation therapies). In
addition to the 14 completed evaluations, reviews for three more tobacco prevention
interventions — youth access restrictions, school-based education, and tobacco industry
and product restrictions — are still under way and will be included in the finished chapter.
USE OF THE RECOMMENDATIONS IN COMMUNITIES AND
HEALTH-CARE SYSTEMS
Given that tobacco use is the largest preventable cause of death in the United States,
reducing tobacco use and ETS exposure should be relevant to most communities. In
selecting and implementing interventions, communities should strive to develop a com-
prehensive strategy to reduce exposure to ETS, reduce initiation, and increase cessa-
tion. Improvements in each category will contribute to reductions in tobacco-related
morbidity and death, and success in one area might contribute to improvements in the
other areas as well. Increasing tobacco-use cessation, for example, will reduce expo-
sure to ETS. Smoking bans, effective in reducing exposure to ETS, also can reduce
daily tobacco consumption for some tobacco users and help others quit entirely.
Choosing interventions that work in general and that are well-matched to local needs
and capabilities and then implementing those interventions well are vital steps for
reducing tobacco use and ETS exposure. In setting priorities for the selection of interven-
tions to meet local objectives, recommendations and other evidence provided in the
Community Guide  should be considered along with such local information as resource
availability, administrative structures, and economic, social, and regulatory environ-
ments of organizations and practitioners. Information regarding applicability can be
used to assess the extent to which the intervention might be useful in a particular set-
ting or population. Though limited, economic information — to be provided in the full
report in 2001 — might be useful in identifying a) resource requirements for interven-
tions, and b) interventions that meet public health goals more efficiently than other
available options. If local goals and resources permit, the use of strongly recommended
and recommended  interventions should be initiated or increased.
A starting point for communities and health-care systems is to assess current
tobacco-use prevention and cessation activities. Current efforts should be compared
with recommendations in this report as well as other relevant program recommenda-
tions proposed by CDC (18 ), the National Cancer Institute (19 ), the Public Health Service
(16 ), the U.S. Department of Health and Human Services (17,20,21 ), and the Institute of
Medicine (22 ). In addition to assessing overall progress toward meeting goals and the
current status of tobacco control efforts, health planners should also consider how to



















TABLE 2. Recommendations regarding selected interventions to reduce exposure to environmental tobacco smoke and to reduce
tobacco use — Task Force on Community Preventive Services, 2000
Intervention Task Force
(no. of qualifying recommendation
studies)  regarding use Intervention description Key findings
Strategies to reduce exposure to environmental tobacco smoke (ETS)
Smoking bans and Strongly recommended Bans or limits tobacco smoking in workplaces Effective in reducing workplace exposure
restrictions (n=10) and public areas (policies, regulations, and laws). to ETS in several different settings and
populations.
Eight studies documented decreases in daily
tobacco consumption among continuing
users.
Three studies documented increased
rates of tobacco-use cessation following
implementation of smoking bans.
Community education Insufficient evidence* Provides information to persons about reducing Insufficient number of studies evaluating the
to reduce home ETS ETS exposure in the home. impact of education efforts on reducing ETS
exposure (n=1) exposure in the home environment.
Strategies to reduce tobacco-use initiation
Increasing the unit price Strongly recommended Increases the excise tax on cigarettes Effective in reducing both initiation and
of tobacco products (n=8) (government legislation). consumption of tobacco by adolescents.
Three studies documented an effect on
consumption and use in young adults
(18-25 years).
Mass media education Strongly recommended Informs viewers through long-term, Effective in combination with other interventions
to reduce tobacco-use high-intensity counteradvertising such as tobacco product price increases,
initiation — campaigns campaigns. school-based education, or community
(n=12) education in reducing tobacco use
by adolescents.


















*A determination that evidence is insufficient should not be seen as evidence of ineffectiveness. A determination of insufficient evidence assists in identifying
a) areas of uncertainty regarding effectiveness of an intervention and b) continuing research needs. In contrast, evidence of ineffectiveness leads to a recommendation
that the intervention not be used.
Strategies to increase tobacco-use cessation, appropriate for communitywide use
Increasing the unit price Strongly recommended Increases the excise tax on cigarettes Effective with or without other interventions
of tobacco products (n=17) (government legislation). such as mass media campaigns.
Effective in reducing population consumption
of tobacco.
Effective in increasing cessation in several
populations.
Mass media education Strongly recommended Informs viewers through long-term, Effective as part of a multicomponent program
to increase tobacco-use high-intensity counteradvertising in reducing population consumption of tobacco.
cessation — campaigns campaigns.
(n=15) Strongest evaluations of effectiveness measured
the impact of multicomponent state tobacco
control programs (California, Oregon,
Massachusetts), which included an excise tax
increase, and school and community education
programs.
Effective in increasing cessation in several
populations.
Mass media education Insufficient evidence* Recruits and motivates tobacco users to quit Insufficient evidence of effectiveness in
to increase tobacco-use during the course of a short-term broadcast increasing  cessation.
cessation — series (n=9) cessation series.
Few studies provided adequate comparison
groups.
Mass media education Insufficient evidence* Recruits and motivates tobacco users Insufficient evidence of effectiveness
to increase tobacco-use to participate in a targeted cessation date. in increasing cessation in the community.
cessation — contests (n=1)
Uses short-term mass media messages Few studies provided adequate comparison




















TABLE 2. (Continued) Recommendations regarding selected interventions to reduce exposure to environmental tobacco smoke
and to reduce tobacco use — Task Force on Community Preventive Services, 2000
Intervention Task Force
(no. of qualifying recommendation
studies)  regarding use Intervention description Key findings
Strategies to increase tobacco-use cessation, appropriate for health-care systems
Multicomponent Strongly recommended Provides information and motivation Effective as part of a multicomponent
tobacco-use cessation to tobacco product users via intervention in both clinical and
interventions that include telephone contact. community settings.
telephone support (n=32)
Proactive telephone support includes The minimum effective combination:
provider-maintained contact. proactive telephone support plus
patient education materials.
Reactive telephone support requires
patient-initiated contact. Mass media efforts were effective
in increasing use of telephone cessation
education and support services.
Multicomponent program Strongly recommended Educates and prompts health-care The combination most frequently evaluated
including — Provider providers to identify, advise, and in the qualifying studies.
reminder system plus assist tobacco-using patients in cessation
provider education efforts. Effective in increasing both patient receipt of
program with or without provider advice to quit and patient tobacco-use
patient education† (n=31) cessation.
Effective in several different clinical settings and
patient populations.
Provider reminder systems Recommended Informs or prompts providers to Effective in increasing patient receipt of provider
(n=7) determine patient’s tobacco-use status advice to quit.
and/or deliver brief advice to quit.
Effective when applied in individual practice
settings and in health-care systems.
Reducing patient out-of- Recommended Reduces or eliminates patient copayments Effective in increasing patient use of the
pocket costs for effective for effective cessation therapies. cessation therapy (pharmacologic therapy with or
without  behavioral program) and in increasing
the total number of patients who quit.
Provider education only Insufficient evidence* Provides information to health-care Insufficient evidence of effectiveness for
(n=16) providers on the importance of cessation provider education interventions alone.
for tobacco-using patients.
Inconsistent evidence of effect on increasing

















Provider feedback (n=3) Insufficient evidence* Provides retrospective assessment of provider Insufficient number of studies providing
performance in delivery of tobacco measurements of changes in provider delivery
cessation advice or assistance to patients. of advice or patient tobacco-use cessation. The
three qualifying studies evaluated the effect of
feedback on provider documentation of smoking
status.
Youth access restrictions Pending Regulates and enforces bans on the purchase or Pending
consumption of tobacco products by children
and adolescents (laws).
School-based education Pending Provides information and motivation to children Pending
and adolescents to diminish the uptake of
tobacco product use.
Tobacco industry Pending Regulates tobacco product content, labeling, Pending
restrictions or industry promotion and advertising (laws).
*A determination that evidence is insufficient should not be seen as evidence of ineffectiveness. A determination of insufficient evidence assists in identifying
a) areas of uncertainty regarding effectiveness of an intervention and b) continuing research needs. In contrast, evidence of ineffectiveness leads to a recommendation
that the intervention not be used.
† The chapter development team did not evaluate evidence of effectiveness of specific tobacco cessation programs (individual or group), pharmacologic therapies,
or provider interactions with patients (e.g., advice or counseling). These interventions were considered to be outside of the chapter focus. The recently updated
Public Health Service cessation guidelines provide an evidence-based review of these interventions (Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use
and dependence. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service, 2000). Because the cessation
guidelines also provide an evaluation of patient education interventions, including supplementary education materials, the team did not evaluate evidence of
the effectiveness of patient education when implemented with or without provider advice or counseling.
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The identification and assessment of existing disparities are critical in selecting and
implementing interventions to assist populations at high risk, such as low-socioeconomic
populations and some racial/ethnic groups (14,18,20 ).
This review did not examine the evidence of effectiveness of clinical cessation pro-
grams or therapies for tobacco dependence, which are not part of the Community Guide
mandate but were addressed in an extensive, evidence-based review recently updated
by the Public Health Service (16 ). However, evidence reviews conducted for the Com-
munity Guide  include several interventions that might be useful to health-care provid-
ers and systems in identifying, advising, and assisting tobacco-using patients in their
efforts to quit. Recommendations in the Community Guide  complement those pro-
vided in the Public Health Service report (16 ), and both publications present a range of
effective options for increasing and improving programs to help patients quit using
tobacco.
ADDITIONAL INFORMATION ABOUT THE COMMUNITY GUIDE
During 2000–2001, Community Guide  chapters will be prepared and released as
each is completed. Upcoming chapters will focus on such topics as motor vehicle occu-
pant injury, oral health, sexual behavior, physical activity, cancer, and the sociocultural
environment. A compilation of the chapters will be published in book form. Additional
information regarding the Task Force and the Community Guide  is available on the
Internet at <http://www.thecommunityguide.org>.
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